Ritedose Corporation
Columbia, SC
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (7)
○ EMA GMP
○ MHRA GMP
Quick Facts: Ritedose Corporation
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Columbia, SC
- Modalities
- BFS plastic unit-dose containers, Sterile ophthalmic, Respiratory/inhalation, Plastic ampoules/vials
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Ritedose Corporation
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesBFS plastic unit-dose containers, Sterile ophthalmic, Respiratory/inhalation, Plastic ampoules/vials
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (4 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press7 articles
Broad modality coverage (4 modalities)
Recent News 7 articles
Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position - GlobeNewswire
Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop - GlobeNewswire
Ritedose Partners with Verona to Deliver Ohtuvayre - Contract Pharma
RiteDose Efficiency Innovation Yields Up to 25% Increase in CDMO Production Capability - GlobeNewswire
Generics Manufacturing: CDMO Selection & Innovation are Keys to Success - Contract Pharma
Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand for Ophthalmic and Respiratory Medications - PR Newswire
Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution - BioSpace
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in: